2019
Risk of second primary malignancies in head and neck cancer patients treated with definitive radiotherapy
Ng S, Pollard C, Kamal M, Ayoub Z, Garden A, Bahig H, Gunn G, Frank S, Skinner H, Phan J, Berends J, Morrison W, Johnson J, Ferrarotto R, Sturgis E, Mohamed A, Lai S, Fuller C, Rosenthal D. Risk of second primary malignancies in head and neck cancer patients treated with definitive radiotherapy. Npj Precision Oncology 2019, 3: 22. PMID: 31583278, PMCID: PMC6764977, DOI: 10.1038/s41698-019-0097-y.Peer-Reviewed Original ResearchSecond primary malignanciesDefinitive radiotherapyFormer smokersCurrent smokersOverall survivalPrimary malignancyRisk of SPMCurative-intent therapyIndex oropharyngeal cancersCompletion of radiotherapySignificant smoking historyKaplan-Meier methodMajority of patientsNeck cancer patientsSame risk factorsNeck cancer treatmentEligible patientsSPM ratesPack yearsSmoking historyOropharyngeal cancerInvasive cancerCancer patientsRisk factorsClinical data
2018
Cost of Surveillance Imaging in Head and Neck Cancer Patients Treated With Definitive Radiation therapy
Ng S, Kamal M, Pollard C, Berends J, Ayoub Z, Mohamed A, Gunn G, Frank S, Skinner H, Phan J, Morrison W, Rosenthal D, Garden A, Johnson J, Lai S, Sturgis E, Fuller C. Cost of Surveillance Imaging in Head and Neck Cancer Patients Treated With Definitive Radiation therapy. International Journal Of Radiation Oncology • Biology • Physics 2018, 100: 1387-1388. DOI: 10.1016/j.ijrobp.2017.12.208.Peer-Reviewed Original ResearchSecond Primary Malignancies in Head and Neck Cancer Patients Treated With Definitive Radiation Therapy
Ng S, Kamal M, Pollard C, Berends J, Ayoub Z, Mohamed A, Gunn G, Frank S, Skinner H, Phan J, Morrison W, Garden A, Johnson J, Ferrarotto R, Lai S, Sturgis E, Fuller C, Rosenthal D. Second Primary Malignancies in Head and Neck Cancer Patients Treated With Definitive Radiation Therapy. International Journal Of Radiation Oncology • Biology • Physics 2018, 100: 1352. DOI: 10.1016/j.ijrobp.2017.12.119.Peer-Reviewed Original Research
2017
Cost of surveillance imaging in head and neck cancer patients treated with definitive radiotherapy.
Ng S, Jomaa M, Pollard C, Ayoub Z, Mohamed A, Garden A, Berends J, Gunn G, Frank S, Skinner H, Phan J, Rosenthal D, Morrison W, Johnson J, Sturgis E, Lai S, Fuller C. Cost of surveillance imaging in head and neck cancer patients treated with definitive radiotherapy. Journal Of Clinical Oncology 2017, 35: 6610-6610. DOI: 10.1200/jco.2017.35.15_suppl.6610.Peer-Reviewed Original ResearchNeck cancer patientsSalvageable recurrenceAsymptomatic patientsDefinitive radiotherapyOverall survivalClinical findingsCancer patientsAdverse clinical findingsEarly salvage treatmentRecurrence-related deathsSuccessful salvage rateDisease-free intervalMedian overall survivalGroup of patientsChemotherapy useEligible patientsLR relapseSalvage therapyDistant relapseSalvage treatmentDisease recurrenceSalvage rateClinical outcomesMedian timeMean age